Fda Approves First Retinal Implant For Rare Eye Disease

Retina Implant

(Reuters) - The U.S. health regulator approved the first implantable device for treating a rare, genetic, eye disease that can lead to blindness.

Sections:  news   living   
Topics:  blindness   eye   eye implant   fda   health   implant   medical   
RELATED ARTICLES
  • Most people aren't meeting exercise guidelines
    Most adults in the USA aren't meeting the federal physical activity recommendations for both aerobic exercise and muscle-strengthening activity, according to government statistics out today. About 79% of adults don't meet the physical activity guidelines that advise getting at least 2½ hours a week of moderate-intensity aerobic activity such as brisk walking, or one hour and 15 minutes a week of vigorous-intensity aerobic activity, such as jogging. More
  • US suicide rate rose sharply among middle-aged
    Health officials say suicides among middle-aged Americans climbed at a startling rate over the past decade, a period that included the recession. Overall, the suicide rate for the age group jumped 28 percent from 1999 to 2010. And among whites, it shot up 40 percent.... More
  • Cost of feeding a family of four: $146 to $289 a week
    Latest statistics give a range of prices for feeding a family of four a healthy diet. The cost of feeding a family of four a healthy diet can run $146 to $289 a week, according to the latest numbers from the U.S. More
  • 2-year-old girl gets windpipe made from stem cells
    A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.... More
  • Study: New bird flu jumped directly from chickens
    Chinese scientists have for the first time found strong evidence of how humans got infected with a new strain of bird flu: from chickens at a live market. In a small study of four patients who caught the new H7N9 virus, Chinese scientists compared swabs from birds at live markets in eastern China to virus samples from patients. More
BING NEWS:
  • FDA delays priority review of Neurotech’s eye cell therapy implant
    Neurotech Pharmaceuticals’ eye cell therapy implant has faced a setback as the US Food and Drug Administration (FDA) has extended its Prescription Drug User Fee Act (PDUFA) date. The US regulatory ...
    11/11/2024 - 4:21 am | View Link
  • FDA Extends Review of CNTF Ocular Implant for Macular Telangiectasia
    NT-501 is an investigational ocular implant that utilizes an encapsulated cell-based delivery system to deliver continuous ciliary neurotrophic factor.
    11/11/2024 - 2:29 am | View Link
  • A Neuralink Rival Says Its Eye Implant Restored Vision in Blind People
    Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.
    10/25/2024 - 7:02 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News